NDC 67046-554-03 - Sertraline Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67046-554
- Requested NDC
- 67046-554-03
- Package NDCs from labels
- 67046-554-30, 67046-554-03
- Manufacturer
- Contract Pharmacy Services-PA | Coupler Enterprises Inc.
- Effective date
- 2021-03-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sertraline Hydrochloride | Contract Pharmacy Services-PA | Coupler Enterprises Inc. | 2021-03-07 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67046-554-30 | 2023-01-30 | C162847 | 48780-1 | f386c64a-0912-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use SERTRALINE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for SERTRALINE HYDROCHLORIDE TABLETS. SERTRALINE HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1991 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67046-554-30 | Sertraline Hydrochloride | 30 in 1 BLISTER PACK | TABLET, FILM COATED | 30 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.